|
US3711492A
(en)
*
|
1970-12-08 |
1973-01-16 |
Basf Ag |
Thiadiazolidinediones
|
|
CA1292686C
(en)
|
1986-10-27 |
1991-12-03 |
Ze'ev Shaked |
Pharmaceutical compositions of recombinant interleukin-2 and formulation process
|
|
CA1294215C
(en)
|
1986-10-27 |
1992-01-14 |
Ze'ev Shaked |
Pharmaceutical compositions of recombinant beta-interferon and formulation processes
|
|
US5530101A
(en)
|
1988-12-28 |
1996-06-25 |
Protein Design Labs, Inc. |
Humanized immunoglobulins
|
|
US5543158A
(en)
|
1993-07-23 |
1996-08-06 |
Massachusetts Institute Of Technology |
Biodegradable injectable nanoparticles
|
|
US5565215A
(en)
|
1993-07-23 |
1996-10-15 |
Massachusettes Institute Of Technology |
Biodegradable injectable particles for imaging
|
|
WO1998027069A1
(en)
*
|
1996-12-17 |
1998-06-25 |
Fujisawa Pharmaceutical Co., Ltd. |
Piperazine compounds as inhibitors of mmp or tnf
|
|
US6045925A
(en)
|
1997-08-05 |
2000-04-04 |
Kansas State University Research Foundation |
Encapsulated nanometer magnetic particles
|
|
JP2002541138A
(ja)
*
|
1999-04-02 |
2002-12-03 |
デュポン ファーマシューティカルズ カンパニー |
マトリックスメタロプロテアーゼ、ＴＮＦ−α、およびアグレカナーゼの阻害剤としての新規アミド誘導体
|
|
US6689794B2
(en)
*
|
2001-05-11 |
2004-02-10 |
Pharmacia Corporation |
Aromatic sulfone hydroxamates and their use as protease inhibitors
|
|
EP1293205A1
(en)
*
|
2001-09-18 |
2003-03-19 |
G2M Cancer Drugs AG |
Valproic acid and derivatives thereof for the combination therapy of human cancers, for the treatment of tumour metastasis and minimal residual disease
|
|
US6676729B2
(en)
|
2002-01-02 |
2004-01-13 |
International Business Machines Corporation |
Metal salt reduction to form alloy nanoparticles
|
|
EP1339075A1
(en)
|
2002-02-25 |
2003-08-27 |
Motorola, Inc. |
Magnetic nanomaterials and synthesis method
|
|
US6878445B2
(en)
|
2002-03-08 |
2005-04-12 |
Fuji Photo Film Co., Ltd. |
Nanoparticle coated material and production method of same
|
|
US7582630B2
(en)
|
2002-10-15 |
2009-09-01 |
Smithkline Beecham Corporation |
Pyradazine compounds as GSK-3 inhibitors
|
|
DE10331439B3
(de)
|
2003-07-10 |
2005-02-03 |
Micromod Partikeltechnologie Gmbh |
Magnetische Nanopartikel mit verbesserten Magneteigenschaften
|
|
JP2006528694A
(ja)
*
|
2003-05-13 |
2006-12-21 |
スミスクライン ビーチャム コーポレーション |
ナフチリジンインテグラーゼインヒビター
|
|
GB0313259D0
(en)
|
2003-06-09 |
2003-07-16 |
Consejo Superior Investigacion |
Magnetic nanoparticles
|
|
US7396589B2
(en)
|
2003-07-31 |
2008-07-08 |
Industrial Technology Research Institute |
Core-shell magnetic nanoparticles comprising an inner-transition element
|
|
TW593158B
(en)
|
2003-07-31 |
2004-06-21 |
Ind Tech Res Inst |
Magnetic nanoparticle
|
|
CN107213469A
(zh)
|
2003-11-06 |
2017-09-29 |
西雅图基因公司 |
能够与配体偶联的单甲基缬氨酸化合物
|
|
GB0402496D0
(en)
*
|
2004-02-04 |
2004-03-10 |
Argenta Discovery Ltd |
Novel compounds
|
|
EP1586318A1
(en)
*
|
2004-04-05 |
2005-10-19 |
Neuropharma S.A.U. |
Thiadiazolidinones as GSK-3 inhibitors
|
|
GB0418328D0
(en)
|
2004-08-17 |
2004-09-22 |
Imp College Innovations Ltd |
Cancer methods and medicaments
|
|
US7462446B2
(en)
|
2005-03-18 |
2008-12-09 |
University Of Washington |
Magnetic nanoparticle compositions and methods
|
|
US7700193B2
(en)
|
2005-04-08 |
2010-04-20 |
Industrial Technology Research Institute |
Core-shell structure with magnetic, thermal, and optical characteristics and manufacturing method thereof
|
|
US20070264199A1
(en)
|
2005-09-26 |
2007-11-15 |
Labhasetwar Vinod D |
Magnetic nanoparticle composition and methods for using the same
|
|
US20090081318A1
(en)
|
2005-12-23 |
2009-03-26 |
Gelbard Harris A |
Treatment of neuroads using inhibitors of glycogen synthase kinase (gsk)-3
|
|
US20090142337A1
(en)
*
|
2006-05-08 |
2009-06-04 |
Astex Therapeutics Limited |
Pharmaceutical Combinations of Diazole Derivatives for Cancer Treatment
|
|
US9180118B2
(en)
*
|
2006-07-18 |
2015-11-10 |
University Of Rochester |
Thiadiazolidinone derivatives
|
|
US8492378B2
(en)
|
2006-08-03 |
2013-07-23 |
Takeda Pharmaceutical Company Limited |
GSK-3β inhibitor
|
|
EP1988098A1
(en)
*
|
2007-04-27 |
2008-11-05 |
AEterna Zentaris GmbH |
Novel Tetrahydrocarbazole Derivatives as Ligands of G-protein Coupled Receptors
|
|
JP5539864B2
(ja)
*
|
2007-06-12 |
2014-07-02 |
アカオゲン，インコーポレーテッド |
抗菌剤
|
|
EP2231147A2
(en)
*
|
2007-12-13 |
2010-09-29 |
Novartis AG |
Combinations of therapeutic agents for treating cancer
|
|
US20120015942A1
(en)
*
|
2010-07-19 |
2012-01-19 |
Millennium Pharmaceuticals, Inc. |
Substituted hydroxamic acids and uses thereof
|
|
BR112014000371A2
(pt)
*
|
2011-07-08 |
2017-01-10 |
Novartis Ag |
derivados de trifluormetil-oxadiazol e uso dos mesmos no tratamento de doença
|
|
DE102011106990B3
(de)
|
2011-07-08 |
2013-01-03 |
Technische Universität Darmstadt |
Verbindungen als Glykogen Synthase Kinase 3 (GSK-3) Inhibitoren für die Behandlung von GSK-3-vermittelten Erkrankungen
|
|
US9371299B2
(en)
*
|
2012-02-24 |
2016-06-21 |
Asd Therapeutics Partners, Llc |
Thiadiazolidinediones as GSK-3 inhibitors
|
|
JP5722264B2
(ja)
|
2012-03-23 |
2015-05-20 |
株式会社日立ハイテクノロジーズ |
データ処理装置、データ容量増加抑制方法
|
|
AU2013343291B2
(en)
*
|
2012-11-07 |
2018-05-10 |
Karus Therapeutics Ltd |
Novel histone deacetylase inhibitors and their use in therapy
|
|
CN103848795B
(zh)
*
|
2014-03-07 |
2016-08-17 |
山东大学 |
一种1,2,5-噁二唑-2-氧化物组蛋白去乙酰化酶抑制剂及其制备方法和应用
|
|
JP6663863B2
(ja)
|
2014-06-12 |
2020-03-13 |
シーダーズ−サイナイ メディカル センター |
がん治療のための組成物及び方法
|